Your browser doesn't support javascript.
loading
Pharmacokinetics and Bioequivalence of a Generic Fixed-Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting Conditions.
Ye, LiJun; Li, Bei; Ling, NengMing; Gao, Yue; Tao, XueXia; Cai, ShuFan; Wang, Yan; Chen, ShaoChun; Wang, Fei.
Affiliation
  • Ye L; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Li B; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Ling N; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Gao Y; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Tao X; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Cai S; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
  • Wang Y; Clinical Research Department, Yangtze River Pharmaceutical Group, Taizhou, JiangSu, P.R. China.
  • Chen S; Nanjing Clinical Tech Laboratories Inc., Nanjing, JiangSu, P.R. China.
  • Wang F; Phase I Clinical Trial Unit, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China.
Clin Pharmacol Drug Dev ; 11(1): 63-70, 2022 01.
Article in En | MEDLINE | ID: mdl-34273258

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metformin Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metformin Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Country of publication: